A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option

被引：2

作者：

Blaiss, Michael ^{[1
]}

DuBuske, Lawrence ^{[2
]}

Nolte, Hendrik ^{[3
]}

Opstrup, Morten ^{[4
]}

Rance, Karen ^{[3
]}

机构：

[1] Med Coll Georgia, Dept Pediat, Augusta, GA USA

[2] George Washington Univ Hosp, Dept Med, Washington, DC USA

[3] ALK, Bedminster, NJ 07921 USA

[4] ALK Abello A S, Horsholm, Denmark

来源：

FRONTIERS IN PEDIATRICS | 2023年 / 11卷

关键词：

allergic rhinitis; allergen immunotherapy; children; checklist; decision tree; management; sublingual; ADVERSE EVENT PROFILE; TIMOTHY GRASS; SLIT-TABLET; RHINITIS; EFFICACY; SAFETY; CHILDREN; MANAGEMENT; COMORBIDITIES; ADOLESCENTS;

D O I：

10.3389/fped.2023.1244146

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Allergic rhinoconjunctivitis (ARC) is a common disease that affects individuals of all ages. Pediatricians may be the first (and only) point of care for children with ARC. Sublingual immunotherapy (SLIT)-tablets are a convenient at-home, injection-free allergy immunotherapy option that can be used for the treatment of ARC. This paper provides a practical guide for pediatricians to aid in prescribing SLIT-tablets to children with ARC in North America. Topics include a summary of the available SLIT-tablets and their efficacy and safety, guidance on when SLIT-tablets are an appropriate option, and how to diagnose ARC and identify culprit allergens. Practical guidance is also provided through a proposed decision tree, a prescribing checklist and prescribing procedures, and suggested follow-up assessments.

引用

页数：9

共 39 条

[11] Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
Anne K. Ellis
Douglas P. Mack
Rémi Gagnon
Eva Hammerby
Sheena Gosain
Allergy, Asthma & Clinical Immunology, 19
[12] Ragweed sublingual immunotherapy (SLIT) tablets in allergic rhinoconjunctivitis: a systematic review and meta-analysis
Sharmila Dhulipalla
European Archives of Oto-Rhino-Laryngology, 2022, 279 : 2765 - 2775
[13] Ragweed sublingual immunotherapy (SLIT) tablets in allergic rhinoconjunctivitis: a systematic review and meta-analysis
Dhulipalla, Sharmila
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (06) : 2765 - 2775
[14] Sublingual five-grass pollen tablets (Oralair®): A guide to their use as allergen immunotherapy for grass pollen-induced allergic rhinoconjunctivitis
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2014, 30 (6) : 200 - 208
[15] SAFETY OF THE HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN A PEDIATRIC ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS TRIAL
Caimmi, D.
Nolte, H.
Pfaar, O.
Foss-Skiftesvik, M.
Osterdal, A.
Schuster, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
[16] Sublingual immunotherapy in pediatric allergic rhinitis and asthma: Efficacy, safety, and practical considerations
Linda Cox
Current Allergy and Asthma Reports, 2007, 7 : 410 - 420
[17] Sublingual immunotherapy in pediatric allergic rhinitis and asthma: Efficacy, safety, and practical considerations
Cox, Linda
CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (06) : 410 - 420
[18] Standardized quality house dust mite sublingual tablets (Acarizax®): a guide to their use as sublingual allergy immunotherapy in Europe
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2016, 32 (12) : 502 - 509
[19] Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis
Durham, SR
Yang, WH
Pedersen, MR
Johansen, N
Rak, S
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (04) : 802 - 809
[20] ONSET OF EFFECT IN A PEDIATRIC HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS TRIAL
Nolte, H.
Caimmi, D.
Schuster, A.
Pfaar, O.
Foss-Skiftesvik, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S19 - S19

← 1 2 3 4 →